Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.06% | -40.79% | -58.18% | -67.85% | -74.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.06% | -40.79% | -58.18% | -67.85% | -74.07% |
| Cost of Revenue | 5.22% | -53.61% | -70.36% | -78.29% | -82.95% |
| Gross Profit | 0.70% | -14.39% | -24.10% | -32.55% | -39.75% |
| SG&A Expenses | -1.37% | -15.89% | -25.95% | -34.24% | -40.30% |
| Depreciation & Amortization | 12.50% | -57.92% | -53.17% | -56.49% | -52.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.50% | -42.96% | -60.05% | -69.33% | -75.04% |
| Operating Income | 11.98% | 10.08% | -0.01% | -10.57% | -30.05% |
| Income Before Tax | 69.09% | -5,680.44% | -1,982.82% | -684.56% | -502.79% |
| Income Tax Expenses | -96.50% | 604.79% | 367.63% | 352.03% | 255.31% |
| Earnings from Continuing Operations | 70.72% | -38,899.91% | -4,665.08% | -1,026.80% | -749.21% |
| Earnings from Discontinued Operations | -8,250.43% | -1,819.14% | -2,230.96% | -190.00% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -203.47% | -2,647.63% | -2,734.35% | -843.49% | -778.15% |
| EBIT | 11.98% | 10.08% | -0.01% | -10.57% | -30.05% |
| EBITDA | 15.39% | -15.50% | -21.81% | -26.40% | -31.78% |
| EPS Basic | -202.54% | -2,642.66% | -2,724.61% | -832.93% | -761.47% |
| Normalized Basic EPS | 0.39% | 13.57% | 2.50% | 27.28% | -19.51% |
| EPS Diluted | -202.81% | -2,632.29% | -2,712.37% | -832.84% | -760.86% |
| Normalized Diluted EPS | 1.18% | 15.78% | 3.41% | 28.72% | -18.74% |
| Average Basic Shares Outstanding | 0.43% | 0.59% | 0.82% | 1.06% | 1.13% |
| Average Diluted Shares Outstanding | -0.03% | -0.35% | 0.78% | 1.02% | 1.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |